UK IVD market accounted for $2.1 billion in 2016,
and is estimated to reach $3.1 billion by 2023, growing at a CAGR of 5.4%
during the analysis period (2017-2023).
In-vitro diagnostics (IVD) is the technique in
which medical devices and reagents are utilized to analyze biological samples
such as blood, urine, stool, tissues, and other body fluids, derived from the
human body to detect diseases and infections. In addition, the tests are
performed in stand-alone laboratory, and hospital-based laboratory. Some of the
significant technologies incorporated in in vitro diagnostics include
polymerase chain reaction, microarray techniques, sequencing technology and
mass spectrometry, which are used for test sample preparation.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/3602
Based on product type, the reagents segment held
the highest market share in 2016, owing to the recent introduction of new
reagents R&D in the filed for chemical science.
Based on technique, the immunodiagnostics segment
contributed the highest market share in 2016, owing to the increase in
prevalence of chronic diseases and rise in demand for minimally invasive
technique.
Based on application, the infectious diseases
segment contributed the highest market share in 2016, due to high rate of the
incidences of infectious diseases and rise in awareness of preventive health
measures.
Based on end users, the standalone laboratory
segment captured the highest market share in 2016, mainly due to wide
availability of complex tests and high-tech infrastructure enabling fast and
accurate test results.
Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/3602
The Major Key Players Are:
·
Thermo Fisher Scientific Inc.
·
Alere Inc.
·
Biomerieux, Danaher Corporation
·
F. Hoffmann-La Roche AG
·
Becton Dickinson and Company
·
Bio-Rad Laboratories
·
Bayer AG
·
Sysmex Corporation
·
Johnson & Johnson.
Key Findings of the UK IVD Market:
- The immunodiagnostics segment dominated the
market in 2016, and is projected to grow at the 5.6% CAGR.
- The immunodiagnostics segment accounted for
the highest share in 2016.
- The pathology segment was the major shareholder
in the UK IVD based application market in 2016.
- The standalone laboratory segment accounted
for the highest share in 2016.
- UK is expected to grow at the highest CAGR in
the IVD market.
Access Full Report @ https://www.alliedmarketresearch.com/uk-ivd-market
About Us:
Allied Market Research (AMR) is a full-service
market research and business -consulting wing of Allied Analytics LLP based in
Portland, Oregon. Allied Market Research provides global enterprises as well as
medium and small businesses with unmatched quality of “Market Research Reports”
and “Business Intelligence Solutions.” AMR has a targeted view to provide
business insights and consulting to assist its clients to make strategic
business decisions and achieve sustainable growth in their respective market
domain.
We are in professional corporate relations with
various companies and this helps us in digging out market data that helps us
generate accurate research data tables and confirms utmost accuracy in our
market forecasting. Each and every data presented in the reports published by
us is extracted through primary interviews with top officials from leading
companies of domain concerned. Our secondary data procurement methodology
includes deep online and offline research and discussion with knowledgeable
professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Comments
Post a Comment